View in EDS HTML Full Text PDF Full Text

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.

Saved in:
Bibliographic Details
Title: Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.
Authors: Nijhuis A; Department of Surgery & Cancer, Imperial College London, London, UK., Sikka A; Department of Surgery & Cancer, Imperial College London, London, UK., Yogev O; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Herendi L; Department of Surgery & Cancer, Imperial College London, London, UK., Balcells C; Department of Surgery & Cancer, Imperial College London, London, UK., Ma Y; Department of Surgery & Cancer, Imperial College London, London, UK., Poon E; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Eckold C; Department of Surgery & Cancer, Imperial College London, London, UK., Valbuena GN; Department of Surgery & Cancer, Imperial College London, London, UK., Xu Y; Department of Surgery & Cancer, Imperial College London, London, UK., Liu Y; Department of Surgery & Cancer, Imperial College London, London, UK., da Costa BM; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Gruet M; Department of Surgery & Cancer, Imperial College London, London, UK., Wickremesinghe C; Department of Surgery & Cancer, Imperial College London, London, UK., Benito A; Department of Surgery & Cancer, Imperial College London, London, UK., Kramer H; Medical Research Council London Institute of Medical Science, London, UK., Montoya A; Medical Research Council London Institute of Medical Science, London, UK., Carling D; Medical Research Council London Institute of Medical Science, London, UK., Want EJ; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Jamin Y; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and Royal Marsden NHS Trust, London, UK., Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Keun HC; Department of Surgery & Cancer, Imperial College London, London, UK. h.keun@imperial.ac.uk.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. h.keun@imperial.ac.uk.
Source: Nature communications [Nat Commun] 2022 Mar 16; Vol. 13 (1), pp. 1380. Date of Electronic Publication: 2022 Mar 16.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35296644
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nijhuis+A%22">Nijhuis A</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sikka+A%22">Sikka A</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Yogev+O%22">Yogev O</searchLink>; Division of Clinical Studies, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Herendi+L%22">Herendi L</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Balcells+C%22">Balcells C</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ma+Y%22">Ma Y</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Poon+E%22">Poon E</searchLink>; Division of Clinical Studies, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Eckold+C%22">Eckold C</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Valbuena+GN%22">Valbuena GN</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22da+Costa+BM%22">da Costa BM</searchLink>; Division of Clinical Studies, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Gruet+M%22">Gruet M</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Wickremesinghe+C%22">Wickremesinghe C</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Benito+A%22">Benito A</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Kramer+H%22">Kramer H</searchLink>; Medical Research Council London Institute of Medical Science, London, UK.<br /><searchLink fieldCode="AU" term="%22Montoya+A%22">Montoya A</searchLink>; Medical Research Council London Institute of Medical Science, London, UK.<br /><searchLink fieldCode="AU" term="%22Carling+D%22">Carling D</searchLink>; Medical Research Council London Institute of Medical Science, London, UK.<br /><searchLink fieldCode="AU" term="%22Want+EJ%22">Want EJ</searchLink>; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Jamin+Y%22">Jamin Y</searchLink>; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and Royal Marsden NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Chesler+L%22">Chesler L</searchLink>; Division of Clinical Studies, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Keun+HC%22">Keun HC</searchLink>; Department of Surgery & Cancer, Imperial College London, London, UK. h.keun@imperial.ac.uk.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. h.keun@imperial.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2022 Mar 16; Vol. 13 (1), pp. 1380. <i>Date of Electronic Publication: </i>2022 Mar 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35296644
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-022-28907-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1380
    Titles:
      – TitleFull: Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nijhuis A
      – PersonEntity:
          Name:
            NameFull: Sikka A
      – PersonEntity:
          Name:
            NameFull: Yogev O
      – PersonEntity:
          Name:
            NameFull: Herendi L
      – PersonEntity:
          Name:
            NameFull: Balcells C
      – PersonEntity:
          Name:
            NameFull: Ma Y
      – PersonEntity:
          Name:
            NameFull: Poon E
      – PersonEntity:
          Name:
            NameFull: Eckold C
      – PersonEntity:
          Name:
            NameFull: Valbuena GN
      – PersonEntity:
          Name:
            NameFull: Xu Y
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: da Costa BM
      – PersonEntity:
          Name:
            NameFull: Gruet M
      – PersonEntity:
          Name:
            NameFull: Wickremesinghe C
      – PersonEntity:
          Name:
            NameFull: Benito A
      – PersonEntity:
          Name:
            NameFull: Kramer H
      – PersonEntity:
          Name:
            NameFull: Montoya A
      – PersonEntity:
          Name:
            NameFull: Carling D
      – PersonEntity:
          Name:
            NameFull: Want EJ
      – PersonEntity:
          Name:
            NameFull: Jamin Y
      – PersonEntity:
          Name:
            NameFull: Chesler L
      – PersonEntity:
          Name:
            NameFull: Keun HC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 03
              Text: 2022 Mar 16
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1